Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c76ecadad74a1a35270b3e3a34d60f37 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D453-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D453-02 |
filingDate |
2005-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d55153344fd940b355ed0cbcb1bb5549 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27f4805c6dbed9a632742a38d0102e8f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46f5e0ce25f7580d55fd6c3c6c70dbca http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f931528d50f6bdf478d58a16001047a |
publicationDate |
2006-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1713801-A1 |
titleOfInvention |
Process for preparation of 1-(2s,3s)-2-benzhydr yl-n-(5-tert-butyl-2-methoxybenzyl)quinuclidin-3-amine |
abstract |
This invention relates to an improved process for the preparation of (2S,3S)- 2-benzhydryl-N-(5-tent-butyl-2-methoxybenzyl)quinuclidin-3-amine, (hereinafter 'compound of Formula I') and its pharmaceutically acceptable salts. In particular, the invention is directed to an improved synthesis of the monohydrate citrate salt of the compound of Formula (la). |
priorityDate |
2004-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |